Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0162-2027

LeadCare II Blood Lead Test Kit. Recall

LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.

FDA recall Class III

Ongoing

FDA lists this Class III recall for LeadCare II Blood Lead Test Kit.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0162-2027
Recall classification
Class III
Enforcement status
Ongoing
Initiation date
Sep 4, 2026
FDA report date
Oct 21, 2026
Quantity in commerce
321 units
Distribution
See key details
FDA cause
Labeling Change Control

What is being recalled?

LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.

Affected model & UDI checker

Search the exact identifiers published for Z-0162-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
70-6762LeadCare II Blood Lead Test Kit.Check source noticeNot specified
FDA code information

Model/Catalog Number: 70-6762. UD-DI: 00850355006000. Lot Number. 2530M-01.

View the original FDA recall notice

Why was this product recalled?

In kit sub-lot 2530M-01 the date of expiration printed on the outer labeling may indicate the wrong expiration date of July 22, 2026 while the correct expiration date is July 13, 2026. If used the system will display an error message and prevent the operator from running the test. Resulting in delayed results.

What actions did Magellan Diagnostics, Inc. take?

Magellan notified consignees on about September 4, 2026, via telephone call indicating a written notification of the recall would follow. On 09/17/2026, a notification letter was emailed to consignees with the following instructions: 1. Complete, sign, and return the CONFIRMATION OF NOTIFICATION FORM. 2. Review your inventory for the affected LeadCare II Blood Lead Test Kit lot identified. 3. Immediately discontinue use of any remaining affected kits. 4. Return any recalled product still in your possession to Magellan Diagnostics, Inc. for destruction.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology